CAMPOCHIARO, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 2.919
EU - Europa 2.694
AS - Asia 1.873
SA - Sud America 280
Continente sconosciuto - Info sul continente non disponibili 233
AF - Africa 35
OC - Oceania 2
Totale 8.036
Nazione #
US - Stati Uniti d'America 2.775
RU - Federazione Russa 1.223
SG - Singapore 667
CN - Cina 577
IT - Italia 482
RO - Romania 439
BR - Brasile 221
HK - Hong Kong 179
VN - Vietnam 167
DE - Germania 117
BD - Bangladesh 101
FR - Francia 95
CA - Canada 85
GB - Regno Unito 76
SE - Svezia 59
IN - India 45
FI - Finlandia 44
NL - Olanda 31
AT - Austria 27
ES - Italia 27
JP - Giappone 25
MX - Messico 23
PL - Polonia 23
AR - Argentina 22
TR - Turchia 16
ZA - Sudafrica 16
LT - Lituania 14
ID - Indonesia 12
MY - Malesia 12
KR - Corea 10
PK - Pakistan 10
EC - Ecuador 8
IQ - Iraq 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
UZ - Uzbekistan 7
CR - Costa Rica 6
JM - Giamaica 6
NO - Norvegia 6
PH - Filippine 6
VE - Venezuela 6
CL - Cile 5
HN - Honduras 5
KE - Kenya 5
LU - Lussemburgo 5
LV - Lettonia 5
NI - Nicaragua 5
TN - Tunisia 5
UA - Ucraina 5
EG - Egitto 4
IE - Irlanda 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
MA - Marocco 3
PT - Portogallo 3
AM - Armenia 2
AU - Australia 2
BE - Belgio 2
BH - Bahrain 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
IL - Israele 2
MD - Moldavia 2
NP - Nepal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MG - Madagascar 1
SI - Slovenia 1
SV - El Salvador 1
Totale 7.804
Città #
Dallas 943
Singapore 380
Ashburn 320
San Jose 241
Moscow 230
Hong Kong 170
Milan 125
Beijing 120
New York 83
Shanghai 82
Council Bluffs 79
Los Angeles 74
Phoenix 63
Santa Clara 63
Hefei 58
Ho Chi Minh City 58
Lauterbourg 50
Munich 39
Boardman 36
Nuremberg 33
Hanoi 29
Denver 24
Orem 23
Rome 22
São Paulo 22
Tokyo 22
Chicago 21
Montreal 21
Brooklyn 19
Toronto 19
Miano 18
Helsinki 17
Naples 17
Poplar 17
Warsaw 17
Atlanta 16
Stockholm 15
Amsterdam 14
Buffalo 14
Guangzhou 14
Johannesburg 14
Lappeenranta 14
Chennai 13
Frankfurt am Main 13
Houston 13
Turku 13
Falkenstein 12
Boston 11
Da Nang 10
Princeton 10
Ankara 9
London 9
Rio de Janeiro 9
City of London 8
Lawrence 8
Mexico City 8
New Delhi 8
San Francisco 8
Secaucus 8
Seongnam-si 8
Vaprio d'Adda 8
Vienna 8
Xi'an 8
Cesano Boscone 7
Haiphong 7
Mugnano di Napoli 7
Mumbai 7
Newark 7
Omaha 7
Seattle 7
Tashkent 7
Turin 7
Belo Horizonte 6
Bergamo 6
Brescia 6
Cagliari 6
Hangzhou 6
Kuala Lumpur 6
Oslo 6
Porto Alegre 6
Querétaro 6
Shenzhen 6
St Louis 6
Ancona 5
Esch-sur-Alzette 5
Hải Dương 5
Kassel 5
Managua 5
Nairobi 5
Padua 5
Palermo 5
Paris 5
Philadelphia 5
Roubaix 5
San José 5
The Dalles 5
Tianjin 5
Augusta 4
Bari 4
Bexley 4
Totale 4.069
Nome #
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 478
Intercalated Disc Abnormalities Are Linked to Arrhythmias in Inflammatory Cardiomyopathy 459
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 361
Monkeypox in a patient with undifferentiated connective tissue disease 260
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 222
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 177
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 166
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 157
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 148
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 145
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 144
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 143
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 132
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis 132
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 132
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 130
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 129
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 128
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 127
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 121
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 121
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands 121
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 120
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 119
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 119
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 116
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome 115
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 114
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review 113
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 112
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 112
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 111
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 111
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 108
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 107
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 105
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 102
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 102
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 101
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 100
VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature 99
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 99
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 98
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art! 98
Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight 94
Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down 90
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 88
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine 87
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 87
HETEROGENEITY OF CYTOPENIAS IN VEXAS SYNDROME: A SINGLE CENTRE EXPERIENCE 86
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 86
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981) 82
Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation 82
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review 74
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review 69
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 69
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 67
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis 65
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 65
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 60
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 59
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis? 57
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational study 35
Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experience 24
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 23
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 22
Association of circulating levels of anti-CarP antibodies with disease activity, disability and radiological damage in rheumatoid arthritis patients: an open-label, observational study 22
Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort 15
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 14
Totale 8.036
Categoria #
all - tutte 28.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 3 1 8 2 2 5 3 2 2
2022/2023109 19 16 9 0 0 13 28 14 4 0 5 1
2023/2024314 4 13 15 30 25 48 38 38 3 18 28 54
2024/20251.457 55 14 39 62 54 89 585 114 132 90 90 133
2025/20265.143 304 608 673 539 392 141 362 343 1.115 248 223 195
2026/2027970 165 205 219 381 0 0 0 0 0 0 0 0
Totale 8.036